Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11148347 | 0.86 | TSHR (0.42) | ALDH1A1TP53TSHR | |
| SCHEMBL512941 | 0.79 | TSHR (0.48) | ALDH1A1TSHR | |
| SCHEMBL18227267 | 0.79 | TSHR (0.33) | ALDH1A1TP53TSHR | |
| SCHEMBL11151060 | 0.78 | ALDH1A1 (0.52) | ALDH1A1TP53TSHR | |
| SCHEMBL11205937 | 0.78 | ALDH1A1 (0.52) | ALDH1A1TP53TSHR | |
| Hydrochloric Acid SCHEMBL7534254 | 0.77 | TSHR (0.46) | ALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL5368847 | 0.77 | TSHR (0.46) | ALDH1A1TSHR | |
| SCHEMBL13104746 | 0.77 | TSHR (0.53) | ALDH1A1TP53TSHR | |
| SCHEMBL10894480 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TP53TSHR | |
| SCHEMBL9066514 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220184104-A1 | SILANOL BASED THERAPEUTIC PAYLOADS | BLINKBIO INC (US) | 2022-06-16 | — | — | US | disclosed |
| US-20210161921-A1 | Silanol Based Therapeutic Payloads | BLINKBIO, INC. | 2021-06-03 | — | — | US | disclosed |
| US-10716801-B2 | Silanol based therapeutic payloads | BLINKBIO, INC. (US) | 2020-07-21 | — | — | US | disclosed |
| US-20190183913-A1 | Silanol Based Therapeutic Payloads | BLINKBIO INC (US) | 2019-06-20 | — | — | US | disclosed |
| US-10293053-B2 | Silanol based therapeutic payloads | BLINKBIO, INC. (US) | 2019-05-21 | — | — | US | disclosed |
| US-20190111142-A1 | Silanol Based Therapeutic Payloads | BLINKBIO, INC. (US) | 2019-04-18 | — | — | US | disclosed |
| US-20180200273-A1 | Silanol Based Therapeutic Payloads | BLINKBIO INC (US) | 2018-07-19 | — | — | US | disclosed |
| US-20180200273-A1 | Silanol Based Therapeutic Payloads | BLINKBIO INC (US) | 2018-07-19 | — | — | US | disclosed |
| EP-0254556-B1 | Semipermeable thin-film membranes comprising siloxane, alkoxysilyl and aryloxysilyl oligomers and copolymers | BEND RES INC (US) | 1994-11-17 | — | — | EP | disclosed |
| US-4781733-A | GAS SEPARATION, POLYCONDENSATION OF POLYFUNCTIONAL COMPOUNDS | BEND RESEARCH, INC. (US) | 1988-11-01 | — | — | US | disclosed |
| EP-0254556-A2 | Semipermeable thin-film membranes comprising siloxane, alkoxysilyl and aryloxysilyl oligomers and copolymers | BEND RESEARCH, INC. (US) | 1988-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190183913-A1 | Silanol Based Therapeutic Payloads | CD47, CD4, BST2 | ALDH1A1 1176/4885TP53 26/4885TSHR 3437/4885 |
| US-20210161921-A1 | Silanol Based Therapeutic Payloads | CD47, CD4, BST2 | ALDH1A1 1176/4885TP53 26/4885TSHR 3437/4885 |
| US-10716801-B2 | Silanol based therapeutic payloads | CD47, CD4, BST2 | ALDH1A1 1176/4885TP53 26/4885TSHR 3437/4885 |
| US-20180200273-A1 | Silanol Based Therapeutic Payloads | CD47, CD4, BST2 | ALDH1A1 1176/4885TP53 26/4885TSHR 3437/4885 |
| US-10293053-B2 | Silanol based therapeutic payloads | CD47, CD4, BST2 | ALDH1A1 1176/4885TP53 26/4885TSHR 3437/4885 |
| US-20190111142-A1 | Silanol Based Therapeutic Payloads | CD47, CD4, BST2 | ALDH1A1 1176/4885TP53 26/4885TSHR 3437/4885 |
| US-20220184104-A1 | SILANOL BASED THERAPEUTIC PAYLOADS | CD47, CD4, BST2 | ALDH1A1 1176/4885TP53 26/4885TSHR 3437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.